CXCL12 and neoplasm: As such, the blockade of CXCR4 in combination with other radiosensitising approaches can be ideal to enhance treatment response and reduce relapse in TNBC by targeting tumour cells and reconstructing the protective microenvironment mediated by CXCR4/CXCL12 signalling [15].